Internal Server Error

TerSera Therapeutics - About the company

TerSera Therapeutics is a series A company based in Lake Forest (United States), founded in 2008. It operates as a Developer and manufacturer of medicines for various therapeutic areas. TerSera Therapeutics has raised $2.68M in funding from CoSci Med-Tech. The company has 2090 active competitors, including 114 funded and 219 that have exited. Its top competitors include companies like AbbVie, Merck and Gilead.

Company Details

TerSera Therapeutics is focused on acquiring and developing pharmaceutical products. The therapeutic areas the company is looking at include allergy/immunology, CNS disorders, endocrinology, gastroenterology, infectious disease, oncology, orphan diseases, rheumatology, transplant-related therapies, urology, and women’s health.
Email ID
*****@tersera.com
Phone Number
+1 **********
Registered Address
Deerfield, Illinois
Key Metrics
Founded Year
2008
Location
Lake Forest, United States
Stage
Series A
Total Funding
$2.68M in 6 rounds
Latest Funding Round
Ranked
Employee Count
214 as on Sep 30, 2026
Investment & Acquisitions
Similar Companies
Sign up to download TerSera Therapeutics' company profile

TerSera Therapeutics's funding and investors

TerSera Therapeutics has raised a total funding of $2.68M over 6 rounds. Its first funding round was on Oct 01, 2010. Its latest funding round was a Series A round on Jun 21, 2016 for $*****. 1 investor participated in its latest round. TerSera Therapeutics has 3 institutional investors.

Here is the list of recent funding rounds of TerSera Therapeutics:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jun 21, 2016
9065264
Series A
2559701
3901307
4923316
5610501
Feb 04, 2016
8576182
Seed
7914803
1984651
4972845
Mar 12, 2013
9023123
Seed
4031168
8216516
4751476
6857649
lockAccess funding benchmarks and valuations. Sign up today!

TerSera Therapeutics' founders and board of directors

Founder? Claim Profile

TerSera Therapeutics' employee count trend

TerSera Therapeutics has 214 employees as of Sep 26. Here is TerSera Therapeutics's employee count trend over the years:
Employee count trend for TerSera Therapeutics
lockUncover TerSera Therapeutics' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

TerSera Therapeutics's Competitors and alternates

Top competitors of TerSera Therapeutics include AbbVie, Merck and Gilead. Here is the list of Top 10 competitors of TerSera Therapeutics, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for AbbVie
AbbVie
2012, Chicago (United States), Public
Research-based biopharmaceutical company
$14.7B
84/100
2nd
Logo for Merck
Merck
1891, Rahway (United States), Public
Manufacturer of pharmaceutical products
-
83/100
3rd
Logo for Gilead
Gilead
1987, Foster City (United States), Acquired
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
-
82/100
4th
Logo for Amgen
Amgen
1980, Thousand Oaks (United States), Public
Developer of pharmaceutical products for treating multiple diseases
-
80/100
5th
Logo for AstraZeneca
AstraZeneca
1999, Cambridge (United Kingdom), Public
Developer of pharmaceutical medicines for oncology and various chronic diseases
-
77/100
6th
Logo for Lilly
Lilly
1876, Indianapolis (United States), Public
Developer of traditional pharmaceutical medicines
-
76/100
7th
Logo for Johnson & Johnson
Johnson & Johnson
1886, New Brunswick (United States), Public
Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products
-
76/100
8th
Logo for Novartis
Novartis
1996, Basel (Switzerland), Acquired
R&D focused on manufacturing of drugs for multiple therapeutic areas
-
72/100
9th
Logo for Roivant Sciences
Roivant Sciences
2014, New York City (United States), Public
Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases
$1.3B
71/100
10th
Logo for Roche
Roche
1896, Basel (Switzerland), Public
Developer of pharmaceuticals and diagnostics kits
-
71/100
46th
Logo for TerSera Therapeutics
TerSera Therapeutics
2008, Lake Forest (United States), Series A
Developer and manufacturer of medicines for various therapeutic areas
$2.68M
61/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on TerSera Therapeutics's competitors? Click here to see the top ones

TerSera Therapeutics's Investments and acquisitions

TerSera Therapeutics has acquired TerSera. TerSera Therapeutics has not made any investments as of now.

Reports related to TerSera Therapeutics

Here is the latest report on TerSera Therapeutics's sector:

News related to TerSera Therapeutics

lockFilter this list
Media has covered TerSera Therapeutics for a total of 2 events in the last 1 year.
•
•
TerSera Therapeutics to Present Data on PRIALT® at ASPN 2025Business Wire•Jul 18, 2025•TerSera Therapeutics
•
TerSera Therapeutics to acquire global rights to MARGENZASeeking Alpha•Oct 22, 2024•TerSera Therapeutics, MacroGenics
•
TerSera’s ZOLADEX LA gains Health Canada approval for breast cancerPharmaceutical Technology•May 08, 2024•TerSera Therapeutics
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about TerSera Therapeutics

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford